Literature DB >> 16636700

High-throughput pharmacokinetic method: cassette dosing in mice associated with minuscule serial bleedings and LC/MS/MS analysis.

Takaho Watanabe1, Daniela Schulz, Christophe Morisseau, Bruce D Hammock.   

Abstract

A method for pharmacokinetic studies using cassette dosing associated with serial bleeding in mice is described. PK profiles of four soluble epoxide hydrolase inhibitors were determined following oral, subcutaneous or intraperitoneal administration individually or in cassette dosing. Parent analyses were performed on only 5 microL of whole blood from serial bleeds (up to 10 per animal), by LC/MS/MS. An accuracy (88-100%) and precision (<10% RSD) were observed, leading to reliable datum points for PK calculation. PK profiles, T(max), C(max) and half-life values after cassette dosing were similar to the individual PK results. This method dramatically increases speed of data collection while dramatically reducing cost and animal usage. The results presented here clearly indicate that this proposed method could be applicable to high-throughput PK studies.

Entities:  

Year:  2006        PMID: 16636700      PMCID: PMC1447531          DOI: 10.1016/j.aca.2005.11.049

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  24 in total

1.  Mechanistic investigation of ionization suppression in electrospray ionization.

Authors:  R King; R Bonfiglio; C Fernandez-Metzler; C Miller-Stein; T Olah
Journal:  J Am Soc Mass Spectrom       Date:  2000-11       Impact factor: 3.109

2.  Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations.

Authors:  B K Matuszewski; M L Constanzer; C M Chavez-Eng
Journal:  Anal Chem       Date:  1998-03-01       Impact factor: 6.986

3.  The simultaneous determination of mixtures of drug candidates by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry as an in vivo drug screening procedure.

Authors:  T V Olah; D A McLoughlin; J D Gilbert
Journal:  Rapid Commun Mass Spectrom       Date:  1997       Impact factor: 2.419

4.  Combinatorial chemistry in drug discovery.

Authors:  J C Hogan
Journal:  Nat Biotechnol       Date:  1997-04       Impact factor: 54.908

5.  Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.

Authors:  Christophe Morisseau; Marvin H Goodrow; John W Newman; Craig E Wheelock; Deanna L Dowdy; Bruce D Hammock
Journal:  Biochem Pharmacol       Date:  2002-05-01       Impact factor: 5.858

6.  Reduction of animal usage by serial bleeding of mice for pharmacokinetic studies: application of robotic sample preparation and fast liquid chromatography-mass spectrometry.

Authors:  K P Bateman; G Castonguay; L Xu; S Rowland; D A Nicoll-Griffith; N Kelly; C C Chan
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-04-15

7.  Rapid determination of soluble epoxide hydrolase inhibitors in rat hepatic microsomes by high-performance liquid chromatography with electrospray tandem mass spectrometry.

Authors:  T Watanabe; B D Hammock
Journal:  Anal Biochem       Date:  2001-12-15       Impact factor: 3.365

8.  Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.

Authors:  In-Hae Kim; Christophe Morisseau; Takaho Watanabe; Bruce D Hammock
Journal:  J Med Chem       Date:  2004-04-08       Impact factor: 7.446

Review 9.  Genetically modified mouse models for pharmacogenomic research.

Authors:  Stephen B Liggett
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

10.  In vitro metabolism of the mammalian soluble epoxide hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea.

Authors:  Takaho Watanabe; Christophe Morisseau; John W Newman; Bruce D Hammock
Journal:  Drug Metab Dispos       Date:  2003-07       Impact factor: 3.922

View more
  25 in total

1.  Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.

Authors:  Stevan Pecic; Shi-Xian Deng; Christophe Morisseau; Bruce D Hammock; Donald W Landry
Journal:  Bioorg Med Chem Lett       Date:  2011-10-28       Impact factor: 2.823

2.  Incorporation of piperazino functionality into 1,3-disubstituted urea as the tertiary pharmacophore affording potent inhibitors of soluble epoxide hydrolase with improved pharmacokinetic properties.

Authors:  Shao-Xu Huang; Hui-Yuan Li; Jun-Yan Liu; Christophe Morisseau; Bruce D Hammock; Ya-Qiu Long
Journal:  J Med Chem       Date:  2010-11-11       Impact factor: 7.446

3.  Development of a high-throughput screen for soluble epoxide hydrolase inhibition.

Authors:  Nicola M Wolf; Christophe Morisseau; Paul D Jones; Bertold Hock; Bruce D Hammock
Journal:  Anal Biochem       Date:  2006-05-11       Impact factor: 3.365

4.  Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs.

Authors:  Hsing-Ju Tsai; Sung Hee Hwang; Christophe Morisseau; Jun Yang; Paul D Jones; Takeo Kasagami; In-Hae Kim; Bruce D Hammock
Journal:  Eur J Pharm Sci       Date:  2010-03-30       Impact factor: 4.384

5.  Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys.

Authors:  A Ulu; Se Appt; C Morisseau; S H Hwang; P D Jones; T E Rose; H Dong; J Lango; J Yang; H J Tsai; C Miyabe; C Fortenbach; M R Adams; B D Hammock
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

6.  A modified serial blood sampling technique and utility of dried-blood spot technique in estimation of blood concentration: application in mouse pharmacokinetics.

Authors:  Vishwanath Kurawattimath; Krishna Pocha; T Thanga Mariappan; Ravi Kumar Trivedi; Sandhya Mandlekar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-09-25       Impact factor: 2.441

7.  Screening candidate anticancer drugs for brain tumor chemotherapy: pharmacokinetic-driven approach for a series of (E)-N-(substituted aryl)-3-(substituted phenyl)propenamide analogues.

Authors:  Hua Lv; Fan Wang; M V Ramana Reddy; Qingyu Zhou; Xiaoping Zhang; E Premkumar Reddy; James M Gallo
Journal:  Invest New Drugs       Date:  2012-03-01       Impact factor: 3.850

Review 8.  The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain.

Authors:  Sean D Kodani; Bruce D Hammock
Journal:  Drug Metab Dispos       Date:  2015-03-11       Impact factor: 3.922

9.  Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase.

Authors:  Alan R Parrish; Gang Chen; Robert C Burghardt; Takaho Watanabe; Christophe Morisseau; Bruce D Hammock
Journal:  Cell Biol Toxicol       Date:  2008-04-03       Impact factor: 6.691

10.  Guidelines for the welfare and use of animals in cancer research.

Authors:  P Workman; E O Aboagye; F Balkwill; A Balmain; G Bruder; D J Chaplin; J A Double; J Everitt; D A H Farningham; M J Glennie; L R Kelland; V Robinson; I J Stratford; G M Tozer; S Watson; S R Wedge; S A Eccles
Journal:  Br J Cancer       Date:  2010-05-25       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.